Pathophysiology of migraine: a disorder of sensory processing

Goadsby, Peter J., Holland, Philip R., Martins-Oliveira, Margarida, Hoffmann, Jan, Schankin, Christoph, Akerman, Simon·2017·Physiological Reviews
DOI 10.1152/physrev.00034.2015

Cited by (1,001)

Items 801–900 of 1,001

  1. Eptinezumab for The Preventive Treatment of Migraine
    Maria Dolores Villar‐Martínez, David Moreno‐Ajona, Peter James Goadsby · 2020 · Pain Management
  2. Real-Life Analysis with Erenumab: First Target Therapy in the Episodic and Chronic Migraine’s Prophylaxis
    Zaira Maraia, Diletta Ricci, Marco Rocchi, Alessandro Moretti, Celestino Bufarini, Arturo Cavaliere, Manola Peverini · 2021 · Journal of Clinical Medicine
  3. Perception of the general population towards migraine in Jeddah, Saudi Arabia
    Hussein A. Algahtani, Bader Hamza Shirah, Mouaz Bamsallm, Kenan Nejaim, Hussain Amin Alobaidi, Meshal Alghamdi · 2022 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
  4. The role of L-DOPA in neurological and neurodegenerative complications: a review
    Sudheendra Rao Kulkarni, Bothe Thokchom, Megha B. Abbigeri, Santosh Mallikarjun Bhavi, Sapam Riches Singh, Nitish Metri, Ramesh Babu Yarajarla · 2025 · Molecular and Cellular Biochemistry
  5. Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches
    Michael A. Moskowitz · 2025 · Cephalalgia
  6. Increased Cortical Excitability in Female Migraineurs: A Transcranial Magnetic Stimulation Study Conducted in the Preovulatory Phase
    Hatice Yüksel, Kamil Topalkara · 2021 · Journal of Clinical Neurology
  7. New characterization of dihydroergotamine receptor pharmacology in the context of migraine: utilization of a β-arrestin recruitment assay
    Lisa A. McConnachie, Peter James Goadsby, Robert E. Vann, Sutapa Ray, Stephen Bevan Shrewsbury, Sheena K. Aurora · 2023 · Frontiers in Neurology
  8. Migraine prodromes and migraine triggers
    Laura H. Fischer-Schulte, Kuan‐Po Peng · 2023 · Handbook of clinical neurology
  9. Induction of cluster headache after opening of adenosine triphosphate-sensitive potassium channels: a randomized clinical trial
    Haidar M. Al‐Khazali, Christina I. Deligianni, Lanfranco Pellesi, Mohammad Al‐Mahdi Al‐Karagholi, Håkan Ashina, Basit Ali Chaudhry, Anja Sofie Petersen, Rigmor Jensen, Faisal Mohammad Amin, Messoud Ashina · 2023 · Pain
  10. Postdromal symptoms in migraine: a REFORM study
    Janu Thuraiaiyah, Håkan Ashina, Rune Häckert Christensen, Haidar M. Al‐Khazali, Messoud Ashina · 2024 · The Journal of Headache and Pain
  11. Is calcitonin gene-related peptide (CGRP) the missing link in food histamine-induced migraine? A review of functional gut-to-trigeminovascular system connections
    Fernando de Mora, Karl Meßlinger · 2024 · Drug Discovery Today
  12. Models of Trigeminal Activation: Is There an Animal Model of Migraine?
    Eleonóra Spekker, Annamária Fejes-Szabó, Gábor Nagy-Grócz · 2024 · Brain Sciences
  13. Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment
    Marina Romozzi, Andrea Burgalassi, Catello Vollono, Maria Albanese, Giulia Vigani, Francesco De Cesaris, Alberto Chiarugi, Paolo Calabresi, Luigi Francesco Iannone · 2024 · Confinia Cephalalgica
  14. Unraveling the interplay of neuroinflammatory signaling between parenchymal and meningeal cells in migraine headache
    Turgay Dalkara, Ζeynep Kaya, Şefik Evren Erdener · 2024 · The Journal of Headache and Pain
  15. The influence of pharmacodynamics and pharmacokinetics on the antimigraine efficacy and safety of novel anti-CGRPergic pharmacotherapies: a narrative review
    Abimael González‐Hernández, Carlos M. Villalón · 2024 · Expert Opinion on Drug Metabolism & Toxicology
  16. Bimodal functions of calcitonin gene-related peptide in the brain
    Kanheng Lin, Jacob Stiles, Willians Tambo, Erum Ajmal, Quanyu Piao, Keren Powell, Chunyan Li · 2024 · Life Sciences
  17. Migraine and cognitive impairment: the interconnected processes
    Arbind Kumar Choudhary · 2024 · Brain-Apparatus Communication A Journal of Bacomics
  18. Treating episodic migraine with precision: the evolving landscape of targeted therapies driven by insights in disease biology
    Robert Fleischmann, Sebastian Strauß, Uwe Reuter · 2025 · Expert Opinion on Biological Therapy
  19. Glutamate as a Therapeutic Substrate in Migraine
    Nazia Karsan, Luiza Bastos Alves, Peter James Goadsby · 2025 · International Journal of Molecular Sciences
  20. Migraine: advances in treatment
    Usman Ashraf, Peter James Goadsby · 2025 · Trends in Molecular Medicine
  21. Calcitonin Gene‐Related Peptide Receptor Antagonists (Gepants) for the Acute Treatment of Nausea in Episodic Migraine: A Systematic Review and Meta‐Analysis
    T. L. H. Chan, R. Cowan, Y. Woldeamanuel · 2020 · Headache
  22. Attention Impairment During the Interictal State in Migraineurs without Aura: A Cross-Sectional Study
    Cheng Chen, Xin Dong, Ping Gu, Keyan Chen, Wan Qi, Haiyue Xie, Zhaochun Shi, Teng Wang · 2021 · Journal of Pain Research
  23. Treatment of chronic migraine and neck pain with cognitive-behavioral therapy. Case report
    Veronika A. Golovacheva, Головачева Анжелика Александровна · 2021 · Consilium Medicum
  24. Cerebrovascular function in tension-type headache and migraine with or without aura: Transcranial Doppler study
    Eman Mohamed Khedr, Mohammed A. Abbas, Ayman Gamea, Mohamed A. Sadek, Ahmed Fathi Zaki · 2022 · Scientific Reports
  25. Vestibular migraine
    Viviane Passarelli Ramin Silva, Luiz Henrique Martins Castro, Marcelo Calderaro · 2022 · Arquivos de Neuro-Psiquiatria
  26. Cerebrospinal Fluid and Plasma Amine Profiles in Interictal Migraine
    Gerrit L.J. Onderwater, Robin M. van Dongen, Amy C. Harms, Ronald Zielman, Willebrordus P. J. van Oosterhout, Jan Bert van Klinken, Jelle J. Goeman, Gisela Marie Terwindt, Arn M. J. M. van den Maagdenberg, Thomas Hankemeier et al. · 2022 · Annals of Neurology
  27. Rimegepant 75 mg in Subjects With Hepatic Impairment: Results of a Phase 1, Open‐Label, Single‐Dose, Parallel‐Group Study
    Rajinder Bhardwaj, Andrea Ivans, Joseph Stringfellow, Beth A. Morris, Vladimir Coric, Robert S. Croop, Richard Bertz · 2023 · Clinical Pharmacology in Drug Development
  28. A New Hybrid Approach Based on Time Frequency Images and Deep Learning Methods for Diagnosis of Migraine Disease and Investigation of Stimulus Effect
    Fırat Orhanbulucu, Fatma Lati̇foğlu, Recep Baydemir · 2023 · Diagnostics
  29. Ox-inflammasome involvement in neuroinflammation
    Andrea Vallese, Valeria Cordone, Alessandra Pecorelli, Giuseppe Valacchi · 2023 · Free Radical Biology and Medicine
  30. Persistent headache attributed to past ischemic stroke: A prospective cohort study
    Felipe Araújo Andrade de Oliveira, Mario Genuíno Dourado Filho, Pedro Augusto Sampaio Rocha‐Filho · 2024 · Headache The Journal of Head and Face Pain
  31. Status Migrainosus in Children and Adults
    Abigail L. Chua, Brian M. Grosberg, Randolph W. Evans · 2019 · Headache The Journal of Head and Face Pain
  32. Views on migraine pathophysiology: Where does it start?
    Lars IH Edvinsson, Kristian Agmund Haanes · 2019 · Neurology and Clinical Neuroscience
  33. Transcranial Direct Current Stimulation and Migraine—The Beginning of a Long Journey
    Samar S. Ayache, Moussa A. Chalah · 2020 · Journal of Clinical Medicine
  34. Emerging Treatment Options for Migraine
    Yi Jing Zhao, Jonathan JY Ong, Peter James Goadsby · 2020 · Annals of the Academy of Medicine Singapore
  35. Galcanezumab for the Prevention of Migraine
    Lindsay Frerichs, Deborah Isa Friedman · 2020 · Pain Management
  36. Lasmiditan for the Acute Treatment of Migraine
    Paul A. DeJulio, Joshua Perese, Nathaniel M. Schuster, Jessica C. Oswald · 2021 · Pain Management
  37. Processing of trigeminocervical nociceptive afferent input by neuronal circuity in the upper cervical lamina I
    Elisabete C. Fernandes, José Carlos-Ferreira, Liliana L. Luz, Éva Kókai, Zoltán Mészár, Péter Szűcs, Boris V. Safronov · 2021 · Pain
  38. Botulinum Neurotoxin Chimeras Suppress Stimulation by Capsaicin of Rat Trigeminal Sensory Neurons In Vivo and In Vitro
    Caren Tatiane de David Antoniazzi, Mariia A. Belinskaia, Tomas H. Zurawski, Seshu Kumar Kaza, James Oliver Dolly, Gary W. Lawrence · 2022 · Toxins
  39. Repetitive Neuromuscular Magnetic Stimulation for Pediatric Headache Disorders: Muscular Effects and Factors Affecting Level of Response
    Corinna Börner, Jacob Staisch, Magdalena Lang, Ari Hauser, Iris Hannibal, Kristina Huß, Birgit Klose, Matthias F. Lechner, Nico Sollmann, Florian Heinen et al. · 2022 · Brain Sciences
  40. Reducing the Burden of Migraine: Safety and Efficacy of CGRP Pathway-Targeted Preventive Treatments
    George R. Nissan, Richard Kim, Joshua M. Cohen, Michael J. Seminerio, Lynda J. Krasenbaum, Karen Carr, Vincent T. Martin · 2022 · Journal of Clinical Medicine
  41. Study of variants in genes implicated in rare familial migraine syndromes and their association with migraine in 200,000 exome‐sequenced UK Biobank participants
    Katherine Alexis Markel, David Curtis · 2022 · Annals of Human Genetics
  42. Study of the Mechanisms and Therapeutic Approaches of Migraine in Women and Pregnancy: A Literature Review
    Jimmy Barus, Harvey Sudharta, Dini Adriani · 2023 · Cureus
  43. Efficacy of tDCS in chronic migraine: A multiprotocol randomized controlled trial
    Mohammad Dawood Rahimi, Mohammad Taghi Kheirkhah, Javad Salehi Fadardi · 2023 · Clinical Neurophysiology
  44. Estrogen-Dependent Changes in Dura Mater Microvasculature Add New Insights to the Pathogenesis of Headache
    Olga V. Glinskii, Virginia H. Huxley, Vladislav V. Glinsky · 2017 · Frontiers in Neurology
  45. Calcitonin Gene-Related Peptide Antagonists for the Prevention of Migraine: Highlights From Pivotal Studies and the Clinical Relevance of This New Drug Class
    Karissa N. Arca, Jenna L. Reynolds, Kara A. Sands, Harn J. Shiue · 2020 · Annals of Pharmacotherapy
  46. Applications of transcranial magnetic stimulation in migraine: Evidence from a scoping review
    Calabrò, Rocco Salvatore, Billeri, Luana, Manuli, Alfredo, Iacono, Antonio, Naro, Antonino · 2022 · Journal of Integrative Neuroscience
  47. Unveiling the Role of Contingent Negative Variation (CNV) in Migraine: A Review of Electrophysiological Studies in Adults and Children
    María Eugenia De Lahoz, Paloma Barjola, Irene Peláez, David Ferrera, Roberto Fernandes-Magalhaes, Francisco Mercado · 2023 · Biomedicines
  48. Shifts in structural connectome organization in the limbic and sensory systems of patients with episodic migraine
    Eunchan Noh, Jong Young Namgung, Yeongjun Park, Yurim Jang, Mi Ji Lee, Bo‐yong Park · 2024 · The Journal of Headache and Pain
  49. Patients’ Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb)
    Elizabeth K. Seng, Christian Lampl, Lars Viktrup, William R. Lenderking, Hayley Karn, Margaret L. Hoyt, Gilwan Kim, Dustin D. Ruff, Michael H. Ossipov, Maurice Borges Vincent · 2024 · Pain and Therapy
  50. Mechanism of Traditional Chinese Medicine in Treating Migraine: A Comprehensive Review
    Qiuyi Chen, Mina Wang, Feiyu Fu, Limin Nie, Quan Miao, Luopeng Zhao, Lu Liu, Bin Li · 2024 · Journal of Pain Research
  51. Machine learning-driven identification of critical gene programs and key transcription factors in migraine
    Lei Zhang, Yujie Li, Yunhao Xu, Wei Wang, Guangyu Guo · 2025 · The Journal of Headache and Pain
  52. Plasma levels of glial fibrillary acidic protein and neurofilament light chain in patients with chronic migraine: a multicenter case-control study
    Eleonora Colombo, Alberto Doretti, Renata Rao, Federico Verde, Martina Sodano, Anna De Gobbi, Francesca Schiano di Cola, Giulia Ceccardi, Beatrice Fiducia, Virginia Quaresima et al. · 2025 · Neurological Sciences
  53. Uncovering longitudinal changes in the brain functional connectome along the migraine cycle: a multilevel clinical connectome fingerprinting framework
    Inês Esteves, Ana R. Fouto, Amparo Ruiz‐Tagle, Gina Caetano, Rita G. Nunes, Nuno André da Silva, Pedro Ferro Vilela, Raquel Gil-Gouveia, Isabel Pavão Martins, César Caballero‐Gaudes et al. · 2025 · The Journal of Headache and Pain
  54. Genetic Interplay Between Attention-Deficit/Hyperactivity Disorder and Pain Suggests Neurodevelopmental Pathways and Comorbidity Risk
    Nicolas Pereira Ciochetti, Victor Fernandes de Oliveira, Iago Junger-Santos, Cibele Edom Bandeira, Maria E. Tavares, Eduardo Schneider Vitola, Luís Augusto Rohde, Gustavo Melo de Andrade, Bruna Santos da Silva, Eugenio Horácio Grevet et al. · 2025 · Biological Psychiatry Global Open Science
  55. Is there a role of calcitonin gene-related peptide in cortical spreading depression mechanisms?– Argument pro
    Marina Romozzi, Paolo Calabresi · 2025 · The Journal of Headache and Pain
  56. Unveiling migraine subtype heterogeneity and risk loci: integrated genome-wide association study and single-cell transcriptomics discovery
    Shuxu Wei, Yan Quan, Xinyi Li, Suiqin Zhong, Ling Xiao, Chao Yang, Ronghuai Shen, Xiaojia Lu, Lingbin He, Youti Zhang et al. · 2025 · The Journal of Headache and Pain
  57. The role of the microbiota-gut-brain axis in schizophrenia: an immunological perspective
    Bo-Wei Su, Yao Li, Le-Ying Yang, Haixia Yang, Wenhao Wang, Huiwen Ren, Ya-Nan Bao, Jia-Yi Lao, Zhi‐Lin Luan · 2025 · Frontiers in Immunology
  58. Noninvasive vagus nerve stimulation and morphine transiently inhibit trigeminal pain signaling in a chronic headache model
    Lauren E. Cornelison, Jordan L. Hawkins, Sara E. Woodman, Paul L. Durham · 2020 · PAIN Reports
  59. Disrupted White Matter Functional Connectivity With the Cerebral Cortex in Migraine Patients
    Zhaoxia Qin, Huaibin Liang, Muwei Li, Yue Hua Hu, Jing Wu, Yuan Qiao, Jian‐Ren Liu, Xiaoxia Du · 2022 · Frontiers in Neuroscience
  60. Presynaptic Interactions between Trigeminal and Cervical Nociceptive Afferents Supplying Upper Cervical Lamina I Neurons
    Elisabete C. Fernandes, José Carlos-Ferreira, Liliana L. Luz, Boris V. Safronov · 2022 · Journal of Neuroscience
  61. High-Density Electroencephalography-Informed Multiband Functional Magnetic Resonance Imaging Reveals Rhythm-Specific Activations Within the Trigeminal Nociceptive Network
    Hauke Basedau, Kuan‐Po Peng, Arne May, Jan Mehnert · 2022 · Frontiers in Neuroscience
  62. Erenumab efficacy in migraine headache prophylaxis: A systematic review
    Mahsa Bagherzadeh-Fard, Mohammad Amin Yazdanifar, Mona Sadeghalvad, Nima Rezaei · 2023 · International Immunopharmacology
  63. Learning headache triggers through experience: A laboratory study
    Dana P. Turner, Timothy T. Houle · 2023 · Headache The Journal of Head and Face Pain
  64. Cervical musculoskeletal impairments and pain sensitivity in migraine patients
    Stefano Di Antonio, Lars Arendt‐Nielsen, Matteo Castaldo · 2023 · Musculoskeletal Science and Practice
  65. Severe obesity is associated with increased migraine severity and frequency: A retrospective cohort study
    Tiam Mana Saffari, Kaitlin J. Kavanagh, Benjamin Ormseth, Marilly S. Palettas, Jeffrey E. Janis · 2023 · Journal of Clinical Neuroscience
  66. Altered functional connectivity in a sensorimotor-insular network during spontaneous migraine attacks: A resting-state FMRI study
    Raquel Pestana Araújo, Patrícia Figueiredo, Joana Pinto, Pedro Ferro Vilela, Isabel Pavão Martins, Raquel Gil‐Gouveia · 2023 · Brain Research
  67. Pathophysiology of migraine
    Carlyn Patterson Gentile, Ana Recober · 2021 · Elsevier eBooks
  68. Practical approaches to improving translatability and reproducibility in preclinical pain research
    Nadia Soliman, Franziska Denk · 2023 · Brain Behavior and Immunity
  69. The anatomy of head pain
    Carrie E. Robertson, Eduardo Elias Benarroch · 2023 · Handbook of clinical neurology
  70. Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study
    Simone Braca, Angelo Miele, Antonio Stornaiuolo, Gennaro Cretella, Roberto De Simone, Cinzia Valeria Russo · 2023 · Neurological Sciences
  71. Different vulnerability of fast and slow cortical oscillations to suppressive effect of spreading depolarization: state-dependent features potentially relevant to pathogenesis of migraine aura
    Tatiana M. Medvedeva, Maria P. Smirnova, Irina V. Pavlova, Lyudmila V. Vinogradova · 2024 · The Journal of Headache and Pain
  72. Comorbidities of migraine: Sleep disorders
    Alexander David Nesbitt · 2024 · Handbook of clinical neurology
  73. Effects of the Dual FAAH/MAGL Inhibitor AKU-005 on Trigeminal Hyperalgesia in Male Rats
    Rosaria Greco, Chiara Demartini, Miriam Francavilla, Anna Maria Zanaboni, Sara Facchetti, Michela Palmisani, Valentina Franco, Cristina Tassorelli · 2024 · Cells
  74. Reduced hepatic impairment study to evaluate pharmacokinetics and safety of zavegepant and to inform dosing recommendation for hepatic impairment
    Rajinder Bhardwaj, Mary K. Donohue, Jennifer Madonia, Beth A. Morris, Thomas C Marbury, Kyle T. Matschke, Robert S. Croop, Richard Bertz, Jing Liu · 2024 · Clinical and Translational Science
  75. Wider range of allodynia in a rat model of repeated dural nociception compared with infraorbital nerve chronic constriction injury
    Guanqun Hu, Mingjie Zhang, Min Su, Qing Zhang, Hangfei Wu, Xiaolin Wang, Zhao Dong, Shengyuan Yu · 2017 · Neuroscience Letters
  76. Resting cranial and upper cervical muscle activity is increased in patients with migraine
    Azin S. Janani, Kenneth James Pope, Nicole Fenton, Tyler S. Grummett, Hanieh Bakhshayesh, Trent W. Lewis, Dean H. Watson, Emma M. Whitham, John Osborne Willoughby · 2018 · Clinical Neurophysiology
  77. Obesity, Migraine, and Overlapping Comorbidities in a Rural Pediatric Population
    Suzy Mascaro Walter, Zheng Dai, Kesheng Wang · 2021 · Journal of Neurosciences in Rural Practice
  78. Progress in the transdermal delivery of antimigraine drugs
    Kevin B. Ita, Monica Ukaoma · 2021 · Journal of Drug Delivery Science and Technology
  79. Inhibition of Nociception in a Preclinical Episodic Migraine Model by Dietary Supplementation of Grape Seed Extract Involves Activation of Endocannabinoid Receptors
    Sara E. Woodman, Sophia R. Antonopoulos, Paul L. Durham · 2022 · Frontiers in Pain Research
  80. Delta opioid receptors in Nav1.8 expressing peripheral neurons partially regulate the effect of delta agonist in models of migraine and opioid-induced hyperalgesia
    Zachariah Bertels, Isaac J. Dripps, Pal V. Shah, Laura S. Moye, Alycia F Tipton, Kendra Siegersma, Amynah A. A. Pradhan · 2022 · Neurobiology of Pain
  81. Cranial autonomic symptoms and response to monoclonal antibodies targeting the Calcitonin gene-related peptide pathway: A real-world study
    Eleonora De Matteis, Valeria Caponnetto, Alfonsina Casalena, Ilaria Frattale, Amleto Gabriele, Giannapia Affaitati, Maria Adele Giamberardino, Maurizio Maddestra, Stefano Viola, Francesca Pistoia et al. · 2022 · Frontiers in Neurology
  82. Qualitative Change in Migraine Prevention?
    Roger K. Cady, Richard B. Lipton · 2018 · Headache The Journal of Head and Face Pain
  83. Diagnostic Accuracy of Serum Calcitonin Gene-Related Peptide and Apolipoprotein E in Migraine: A Preliminary Study
    Rabia Latif, Nazish Rafique, Lubna Ibrahim Al Asoom, Ahmed Abdulrahman Alsunni, Ayad Mohammed Salem, Dinah Abdulhadi AlNoaimi, Wasan M Alharbi, Ahad Yasir Shaikh, Shoug Abdullah AlRaddadi, Leena Abdulrahman Almuhaish et al. · 2021 · International Journal of General Medicine
  84. Calcitonin gene-related peptide receptor antagonist ubrogepant for the treatment of acute migraine
    Zizhen Zhang, Yunfeng Shu, Yun Peng Diao, Yang Du, Lizhi Chen, Ying Liu, DU Biao · 2021 · Medicine
  85. Migraine Type-Dependent Patterns of Brain Activation After Facial and Intranasal Trigeminal Stimulation
    Antje Haehner, Gudrun Goßrau, Franziska Bock, Thomas R. Hummel, Emilia Iannilli · 2022 · Brain Topography
  86. Similarities and differences between migraine and other types of headaches: Migraine mimics
    Isın Ünal-Çevik, Doruk Arslan · 2023 · Neurology Perspectives
  87. SIRT1-regulated ROS generation activates NMDAR2B phosphorylation to promote central sensitization and allodynia in a male chronic migraine rat model
    Xiaoyan Zhang, Wei Zhang, Yanyun Wang, Yun Zhang, Dunke Zhang, Guangcheng Qin, Jiying Zhou, Lixue Chen · 2024 · Frontiers in Molecular Neuroscience
  88. Cluster Headache and Migraine Shared and Unique Insights: Neurophysiological Implications, Neuroimaging, and Biomarkers: A Comprehensive Review
    Gabriele Bertotti, Vicente Fernández-Ruiz, Alberto Roldán‐Ruiz, Miguel López‐Moreno · 2025 · Journal of Clinical Medicine
  89. Fibroblast reprogramming in the dura mater of NTG-induced migraine-related chronic hypersensitivity model drives monocyte infiltration via Angptl1-dependent stromal signaling
    Guangyu Guo, Lei Zhang, Xuyang Liu, Yiping Deng, Peiyu Wu, Ruofan Zhao, Wei Wang · 2025 · The Journal of Headache and Pain
  90. Concomitant anti-CGRP and immunomodulatory treatments in patients with migraine: towards integrated management strategies
    María Clara García-Castillo, Álvaro Sierra, Edoardo Caronna, Daniel Toledo-Alfocea, Alex Jaimes, Sarai Urtiaga, Javier Casas‐Limón, Albert Muñoz‐Vendrell, Sonia Santos Lasaosa, Vince Martin et al. · 2025 · Journal of Neurology
  91. Beyond the Surface: Investigating the Potential Mechanisms of Non‐Motor Symptoms in Myasthenia Gravis
    Benqiao Wang, Dan Liu, Yingying Yang, Ruixia Zhu · 2025 · European Journal of Neurology
  92. Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
    Richard B. Lipton, Jonathan Stokes, Christopher J. Evans, Elizabeth Hribal, Kailee White, Katelyn R. Keyloun, Krutika Jariwala‐Parikh, Pranav Gandhi, David W. Dodick · 2025 · Headache The Journal of Head and Face Pain
  93. The Use of Botulinum Toxin in the Management of Headache Disorders
    Hsiangkuo Yuan, Stephen David Silberstein · 2020 · Handbook of experimental pharmacology
  94. Advocacy for Migraine Relief: Strategic Planning to Eliminate the Burden
    Teshamae Monteith · 2022 · Current Pain and Headache Reports
  95. Neurovascular Compression-Induced Intracranial Allodynia May Be the True Nature of Migraine Headache: an Interpretative Review
    Valdas Macionis · 2023 · Current Pain and Headache Reports
  96. Global Epidemiology, Clinical Features, Diagnosis and Current Therapeutic Novelties in Migraine Therapy and their Prevention: A Narrative Review
    Mohammad Daud Ali, Fehmida Gayasuddin Qur, Md Sarfaraz Alam, Nawaf Alotaibi, Md Ali Mujtaba · 2023 · Current Pharmaceutical Design
  97. Study on the correlation between IL-12p70, IL-17A and migraine in children
    Fan Yang, Hai-zhen Liu, Jia-ai Liu, Yao-yao Chen, Suzhen Sun · 2024 · Frontiers in Neurology
  98. Rodents’ visual gamma as a biomarker of pathological neural conditions
    Nicolò Meneghetti, Eleonora Vannini, Alberto Mazzoni · 2024 · The Journal of Physiology
  99. Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine
    Jeanne Rossignol, Tanja Ouimet, Hervé Poras, Radhouane Dallel, Philippe Luccarini · 2024 · Headache The Journal of Head and Face Pain
  100. Voltage-gated Calcium Channels as Potential Therapeutic Targets in Migraine
    Juliana Geremias Chichorro, Eder Gambeta, Darciane Favero Baggio, Gerald Werner Zamponi · 2024 · Journal of Pain